Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
Cancer Research|February 1, 1983
Kinetics and metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine, in humansJ P Sommadossi, C Aubert, J P Cano, et al.
La Nouvelle Presse Medicale|June 28, 1980
[The management of ovarian adenocarcinoma. "Second look" surgical operation after chemotherapy (author's transl)]J L Misset, R Marnich, G Michel, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Regression of the malignant aspects of intraepithelial neoplasias following an LH-RH agonist treatment and detection of human papillomavirus by molecular hybridizationH Kitasato, B Fabiani, M Busuttil, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1984
Cytological and immunological study of 139 patients with acute leukemiaJ Minowada, G Mathé, M Barcos, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
A comparative trial of a MAOI, iproniazide, and a polycyclic agent, mianserine, for the search of the most rapidly and frequently active treatment of depressive syndromes in an oncology serviceG Mathé, M D Lopez, M Fréchet, et al.
Cancer Treatment Reports|December 1, 1985
Circadian rhythm in tolerance of mice for etoposideF Lévi, M Mechkouri, A Roulon, et al.
Cancer Research|June 1, 1984
A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumorsF A Levi, J P Blum, G Lemaigre, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1981
Cellular blood fluorescence polarization: a possible prognostic tool in human acute lymphatic leukemiaC Jasmin, Y Augery, F Calvo, et al.
Anti-Cancer Drug Design|June 1, 1988
On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NUA Carminati, J L Barascut, E Chenut, et al.
Infection|November 9, 2022
Long-term follow-up after introduction of a systematic sexually transmitted infection screening program for men having sex with men living with HIV in a primary care setting: uptake, STI incidence, and risk factors for infection and reinfectionPhilipp J G Mathé, Susanne Usadel, Siegbert Rieg, et al.
Pageof 29